Page 22 - Tim Boreham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health & Wellness Boom On The ASX This story features EZZ Life Science Holdings Ltd, and other companies. For more info SHARE ANALYSIS: EZZ You beauty! Health and wellness stocks that deliver prosperity and vitality By Tim Boreham, Editor, The New Criterion It seems the only advertisers these days are Harvey Norman, sports betting shops and Chemist Warehouse and Priceline with their pages of pills and unguents. Indeed, the term “health and wellness” might be overused and even tautologous, but tell that to the average household that spends many billions of dollars annually on cosmetics, di...

Cash For Trash In Listed Waste Management Listed waste management options that are not rubbish By Tim Boreham, Editor, The New Criterion Not for the first time, the listed waste management sector is in the throes of ownership upheaval as investors await the fallout from this month’s proposed $20bn merger of the French-based giants Veolia Group and Suez Group. The outcome has direct implications for the largest ASX listed waste manager, Cleanaway Waste Management ((CWY)). In the meantime skip operator Bingo Industries ((BIN)) is subject to a tentative $2.5bn buyout offer from private equit...

Crafting Opportunities One Chug At A Time Here’s cheers: the craft beer market offers plenty of upside to the discerning operators By Tim Boreham, Editor, The New Criterion Investors thirsting for an ASX beer exposure have been left largely unsated since Fosters/Carlton United Breweries and Lion Nathan were subsumed by foreign buyers a few years back. Coca Cola Amatil (CCL) has long held beer and spirits ambitions that have never quite come to fruition, but in any event the bottler looks headed to offshore ownership as well. But as any self-respecting hipster would know, all the action is t...

The War For Drugs By Tim Boreham, Editor, The New Criterion The mere mention of magic mushrooms, ecstasy or ketamine is enough to send parents of teenagers into conniptions. But are these so-called party drugs poised to follow cannabis into the realm of a medical treatment within a legitimate listed sector? As a likely precursor to more local action in the (mind) expanding field, cannabis play Creso Pharma (CPH) this month said it would acquire the privately-owned Nova Scotia based Halucenex Life Sciences. Capitalising on the 21 per cent share bounce after the deal was unveiled on March 15, ...

Government Regulation And The Stock Market The companies that live or die with the stroke of a regulatory pen By Tim Boreham, Editor, The New Criterion Deep in any corporate vault lies a piece of paper or two that affirms the right of an enterprise to operate, such as articles of incorporation, a banking or broadcasting licence or a mining permit. Apart from diligent company secretaries, no one else will give the paperwork a second thought. But when this right to operate is threatened, the anxiety level quickly rises. Nothing exemplifies the dangers more than the stricken Crown Resorts ((CWN...